APWA
BNTX icon

Atlas Private Wealth Advisors’s BioNTech BNTX Stock Holding History

Atlas Private Wealth Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-118
Closed -$26K – 751
2021
Q2 		$26K Sell
118
-100
-46% -$18.9K 0.01% 314
2021
Q1 		$24K Hold
218
– – 0.01% 335
2020
Q4 		$18K Hold
218
– – 0.01% 343
2020
Q3 		$15K Buy
+218
New +$15.6K 0.01% 344

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Atlas Private Wealth Advisors's BNTX Position: Q3 2021 in Review

Atlas Private Wealth Advisors sold out of BioNTech (BNTX) in Q3 2021, closing a stake of 118 shares — an estimated $26K sold.

Atlas Private Wealth Advisors first reported a position in BNTX in Q3 2020 and held it in 4 quarters. The position peaked at $26K in Q2 2021. 335 funds tracked by Wall St. Rank hold BNTX as of Q3 2021.

  • Atlas Private Wealth Advisors reported no remaining BioNTech position as of Q3 2021 after selling out during the quarter.
  • Atlas Private Wealth Advisors sold 118 BioNTech shares in Q3 2021, an estimated $26K.
  • Atlas Private Wealth Advisors first reported a position in BioNTech in Q3 2020 and held it in 4 quarters.
  • Atlas Private Wealth Advisors's BioNTech position peaked at $26K in Q2 2021.
  • 335 funds tracked by Wall St. Rank held BioNTech as of Q3 2021.

Based on Atlas Private Wealth Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.